Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 5/10/13  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Edward V. Fritzky

Wrong Edward V. Fritzky?

Member

Phone: (650) ***-****  HQ Phone
Geron Corporation
149 Commonwealth Drive Suite 2070
Menlo Park, California 94025
United States

Company Description: Geron Corporation (Geron), is developing therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • B.A. degree
    Duquesne University
  • Graduate of the Advanced Executive Program
    J.L. Kellogg Graduate School of Management at Northwestern University
195 Total References
Web References
Jacobs Engineering : Providers of Professional, Technical, and Construction Services
www.c-b.com, 10 May 2013 [cached]
Edward V. Fritzky (Chair) Jacobs Engineering : Providers of Professional, Technical, and Construction Services
...
Home > About > Corporate Governance > Edward V. Fritzky
...
Edward V. Fritzky Director since 2004
...
Mr. Fritzky, age 61, is retired. Mr. Fritzky served on the Board of Amgen, Inc., a global biotechnology company that discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology, from July 2002 to May 2005 and also served as a special advisor to Amgen until July 2004.
From January 1994 to July 2002, Mr. Fritzky served as Chief Executive Officer, President and Chairman of the Board of Immunex Corporation, a biotechnology company. From March 1989 to January 1994, he was President and Vice President of Lederle Laboratories, a division of American Cyanamid Company, a pharmaceutical company.
Mr. Fritzky serves as a member of the Board of Geron Corporation.
SEC EDGAR Submission 0001206774-05-000436
www.sec.gov, 24 Mar 2005 [cached]
The Class II directors, Thomas D. Kiley, Esq. and Edward V. Fritzky, have two years remaining on their term of office.
...
Edward V. Fritzky
...
Edward V. Fritzky has served as a director of the Company since July 1998.He currently serves as a director and advisor to Amgen Corporation.He served as Chief Executive Officer and Chairman of Immunex Corporation from January 1994 to July 2002.Mr. Fritzky is also a director of Sonosite, Inc. and Jacobs Engineering Group, Inc.Mr. Fritzky served as President of Lederle Laboratories, a division of American Cyanamid, from 1992 to 1994, and as Vice President of Lederle Laboratories from 1989 to 1992.Prior to joining Lederle Laboratories, Mr. Fritzky was an executive of Searle Pharmaceuticals, Inc., a subsidiary of the Monsanto Company.During his tenure at Searle, Mr. Fritzky was Vice President of Marketing in the United States, and later President and General Manager of Searle Canada, Inc. and Lorex Pharmaceuticals, a joint venture company.Mr. Fritzky holds a B.A. from Duquesne University and is a graduate of the Advanced Executive Program, J.L. Kellogg Graduate School of Management at Northwestern University.
...
Fritzky, Kiley and Walker, met seven times in 2004 and acted by written consent on two occasions.
...
The members of the Nominating Committee are Dr. Barkas and Mr. Fritzky.
The Class II directors, Edward V. ...
www.sec.gov, 3 April 2012 [cached]
The Class II directors, Edward V. Fritzky, Hoyoung Huh, M.D., Ph.D., and Thomas D. Kiley, Esq., have one year remaining on their terms of office.
...
Edward V. Fritzky
...
Edward V. Fritzky has served as a director of the Company since July 1998. From July 2002 to May 2005, he served as a director and advisor to Amgen Corporation, a U.S. pharmaceutical company, where he established a leading research center in Seattle. From January 1994 to July 2002, he served as Chief Executive Officer and Chairman of Immunex Corporation, a biopharmaceutical company that developed, manufactured, and marketed therapeutic products for the treatment of cancer, infectious diseases, and autoimmune disorders, during which
...
Since 2004, Mr. Fritzky has been a director of Jacobs Engineering Group, Inc., a professional technical services firm providing scientific and specialty consulting services supporting industrial, commercial and government clients. From 1998 to 2009, Mr. Fritzky was a director of Sonosite, Inc., a leading company of hand-carried ultrasound equipment. From 1992 to 1994, Mr. Fritzky served as President of Lederle Laboratories, a division of American Cyanamid, and from 1989 to 1992, as Vice President of Lederle Laboratories. While at Lederle Laboratories, Mr. Fritzky oversaw the launch of six new products. Prior to joining Lederle Laboratories, Mr. Fritzky was an executive of Searle Pharmaceuticals, Inc., a subsidiary of the Monsanto Company that manufactures, develops and markets health care products and pharmaceuticals. During his tenure at Searle, Mr. Fritzky was Vice President of Marketing in the United States and later President and General Manager of Searle Canada, Inc. and Lorex Pharmaceuticals, a joint venture between G.D. Searle & Company, a U.S. pharmaceutical company, and Synthelabo, a French pharmaceutical company, to market existing and new Synthelabo products in the United States. Mr. Fritzky served as a Trustee of the Fred Hutchinson Cancer Center from July 2001 to June 2007. Mr. Fritzky holds a B.A. from Duquesne University and is a graduate of the Advanced Executive Program, J.L. Kellogg Graduate School of Management at Northwestern University.
The Board believes Mr. Fritzky’s management and operational experience as Chairman and Chief Executive Officer of Immunex Corporation and as President of other biopharmaceutical companies, his knowledge of therapeutic product launches and the substantial understanding of the Company and its operations he has gained during his 14 years as a director of the Company, qualifies Mr. Fritzky to serve as a director.
BIO | BIO Announces 2002-2003 Board of Directors
bio.org, 11 Nov 2009 [cached]
Edward V. Fritzky Chairman, CEO, and President Immunex Corporation
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304